MedPath

Effectiveness and Cost effectiveness of mindfulness class for anxiety disorders

Phase 3
Conditions
Anxiety disorders
Registration Number
JPRN-UMIN000015412
Lead Sponsor
Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

/Past history of substance related disorders /Alcohol dependence /Drug dependence /Anti social personality disorder /Severe suicidal ideation or self-harm behaviour /Difficult to follow up for 8 weeks after start of intervention /Dissent to the possibility of being allocated to the control group /Organic brain disorders /Other severe general medical conditions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference of STAI score between both groups
Secondary Outcome Measures
NameTimeMethod
Panic Disorder Severity Scale, Morbility Inventory for Agoraphobia, LSAS-J, CES-D, K-6, EQ-5D, SF-36, Japanse version Five Facet Mindlfulness Questionnaire, SAA, healthcare service use, and adherence to medication.
© Copyright 2025. All Rights Reserved by MedPath